Wender Joseph H.'s most recent trade in Ionis Pharmaceuticals Inc was a trade of 20,571 Common Stock done at an average price of $80.7 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 80.67 per share. | 01 Dec 2025 | 20,571 | 43,464 (0%) | 0% | 80.7 | 1,659,362 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 81.23 per share. | 01 Dec 2025 | 7,429 | 36,035 (0%) | 0% | 81.2 | 603,486 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 18 Nov 2025 | 16,000 | 16,000 (0%) | 0% | 24.4 | 390,720 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 75.16 per share. | 30 Oct 2025 | 11,200 | 64,035 (0%) | 0% | 75.2 | 841,776 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 73.16 per share. | 30 Oct 2025 | 8,341 | 81,210 (0%) | 0% | 73.2 | 610,228 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 73.85 per share. | 30 Oct 2025 | 5,975 | 75,235 (0%) | 0% | 73.9 | 441,254 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 72.19 per share. | 30 Oct 2025 | 2,484 | 89,551 (0%) | 0% | 72.2 | 179,320 | Common Stock |
| Ionis Pharma Inc | Wender Joseph H. | Director | Sale of securities on an exchange or to another person at price $ 65.50 per share. | 01 Oct 2025 | 16,800 | 92,035 (0%) | 0% | 65.5 | 1,100,385 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 60.14 per share. | 02 Sep 2025 | 11,200 | 108,835 (0%) | 0% | 60.1 | 673,549 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 55.04 per share. | 02 Sep 2025 | 11,200 | 125,635 (0%) | 0% | 55.0 | 616,432 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 55.04 per share. | 02 Sep 2025 | 11,200 | 125,635 (0%) | 0% | 55.0 | 616,432 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 60.14 per share. | 02 Sep 2025 | 11,200 | 108,835 (0%) | 0% | 60.1 | 673,549 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 57.53 per share. | 02 Sep 2025 | 5,600 | 120,035 (0%) | 0% | 57.5 | 322,174 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 57.53 per share. | 02 Sep 2025 | 5,600 | 120,035 (0%) | 0% | 57.5 | 322,174 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 4,079 | 136,835 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 4,079 | 1,141 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 11,518 | 11,518 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 5,220 | 9,299 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 10,125 | 69,225 (0%) | 0% | 0 | Common Stock | |
| Outfront Media Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 10,125 | 0 | - | - | Restricted Share Units | |
| Outfront Media Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 771 | 69,996 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 4,677 | 4,079 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 4,677 | 132,756 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 10,111 | 10,111 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 4,079 | 8,756 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Joseph H. Wender | Director | 06 Jun 2024 | 9,863 | 0 | - | - | Restricted Share Units | ||
| Outfront Media Inc | Joseph H. Wender | Director | 06 Jun 2024 | 9,863 | 58,732 (0%) | 0% | 0 | Common Stock | ||
| Outfront Media Inc | Joseph H. Wender | Director | 06 Jun 2024 | 624 | 59,356 (0%) | 0% | 0 | Common Stock | ||
| Outfront Media Inc | Joseph H. Wender | Director | 03 Jun 2024 | 10,125 | 10,125 | - | - | Restricted Share Units | ||
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.53 per share. | 09 May 2024 | 16,000 | 128,079 (0%) | 0% | 35.5 | 568,480 | Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 4,677 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 112,079 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,777 | 106,746 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,777 | 10,010 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 10,321 | 10,321 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 4,677 | 11,787 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Joseph H. Wender | Director | 06 Jun 2023 | 9,863 | 9,863 | - | - | Restricted Share Units | ||
| Outfront Media Inc | Joseph H. Wender | Director | 06 Jun 2023 | 7,290 | 48,293 (0%) | 0% | 0 | Common Stock | ||
| Outfront Media Inc | Joseph H. Wender | Director | 06 Jun 2023 | 7,290 | 0 | - | - | Restricted Share Units | ||
| Outfront Media Inc | Joseph H. Wender | Director | 06 Jun 2023 | 576 | 48,869 (0%) | 0% | 0 | Common Stock | ||
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 5,333 | 9,775 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 5,333 | 102,304 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,665 | 104,969 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,665 | 7,110 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 5,333 | 15,108 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Joseph H. Wender | Director | 07 Jun 2022 | 7,290 | 7,290 | - | - | Restricted Share Units | ||
| Outfront Media Inc | Joseph H. Wender | Director | 07 Jun 2022 | 4,907 | 0 | - | - | Restricted Share Units | ||
| Outfront Media Inc | Joseph H. Wender | Director | 07 Jun 2022 | 4,907 | 40,802 (0%) | 0% | 0 | Common Stock | ||
| Outfront Media Inc | Joseph H. Wender | Director | 07 Jun 2022 | 201 | 41,003 (0%) | 0% | 0 | Common Stock | ||
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 5,333 | 93,638 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 5,333 | 13,108 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 1,778 | 9,775 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 1,778 | 96,971 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 889 | 94,527 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 889 | 12,219 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 666 | 95,193 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 666 | 11,553 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 5,333 | 18,441 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Joseph H. Wender | Director | 08 Jun 2021 | 6,366 | 0 | - | - | Restricted Share Units | ||
| Outfront Media Inc | Joseph H. Wender | Director | 08 Jun 2021 | 6,366 | 35,895 (0%) | 0% | 0 | Common Stock | ||
| Outfront Media Inc | Joseph H. Wender | Director | 08 Jun 2021 | 4,907 | 4,907 | - | - | Restricted Share Units |